Cytokine Release in HR-HPV(+) Women without and with Cervical Dysplasia (CIN II and III) or Carcinoma, Compared with HR-HPV(−) Controls
2007

Cytokine Release in Women with HR-HPV and Cervical Dysplasia

Sample size: 39 publication Evidence: moderate

Author Information

Author(s): Aagje G. Bais, Ilse Beckmann, Patricia C. Ewing, Marinus J. C. Eijkemans, Chris J. L. M. Meijer, Peter J. F. Snijders, Theo J. M. Helmerhorst

Primary Institution: Erasmus University Medical Center

Hypothesis

The study investigates the effect of HR-HPV infection on the cytokine network during cervical carcinogenesis.

Conclusion

HR-HPV infection without cervical dysplasia activates the cytokine network, and significant changes in cytokine release occur as cervical dysplasia progresses.

Supporting Evidence

  • HR-HPV-positive women without dysplasia showed significant increases in cytokine release.
  • Th1-type cytokines decreased with increasing grades of CIN.
  • IL-10 and IL-4 levels peaked in patients with CIN III.

Takeaway

The study found that women with HR-HPV can have changes in their immune response even if they don't have cervical dysplasia, and these changes can lead to cancer.

Methodology

The study involved whole blood cultures from women with varying grades of cervical dysplasia and HR-HPV status, stimulated with phytohemagglutinin to measure cytokine release.

Potential Biases

Potential selection bias due to exclusion criteria for participants.

Limitations

The small sample size may limit the generalizability of the findings.

Participant Demographics

The study included women with different grades of cervical dysplasia and HR-HPV status, with a mean age significantly lower in HR-HPV-positive women without dysplasia.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1155/2007/24147

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication